Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
Lexicon Pharmaceuticals (Nasdaq: LXRX) will report first quarter 2026 financial results on May 7, 2026 before the market opens.
Rhea-AI Summary
Lexicon Pharmaceuticals (Nasdaq: LXRX) will report first quarter 2026 financial results on May 7, 2026 before the market opens. Management will host a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) to discuss results and provide a business update.
Access the live webcast via the company Events page and use the dial-in to ask questions; an archived webcast will be posted after the call.
Positive
- None.
Negative
- None.
Details
News Market Reaction – LXRX
In the Apr 30 session, LXRX gained 3.87%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings release date
- May 7, 2026
- First quarter 2026 financial results release before market open
- Conference call time ET
- 8:30 a.m. ET
- Management call to discuss Q1 2026 results and business update
- Conference call time CT
- 7:30 a.m. CT
- Central time for Q1 2026 results conference call
- Dial-in phone number
- 800-715-9871
- Participant access line for Q1 2026 conference call
- Conference passcode
- 9826247
- Passcode required for phone participants to join Q1 2026 call
Previous Earnings date Reports
-
Announced timing and 8:30 a.m. ET call for Q4 2025 results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
THE WOODLANDS, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its first quarter 2026 financial results on Thursday, May 7, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update.
Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may join by phone at 800-715-9871 and use passcode 9826247. An archived version of the webcast will be available on the Lexicon website.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.